TRPC2: A Potential Drug Target and Biomarker (G7221)

Target Name: TRPC2

NCBI ID: G7221

TRPC2

Other Name(s): transient receptor potential cation channel subfamily C member 2 (pseudogene) | Transient receptor potential cation channel subfamily C member 2 (pseudogene)

TRPC2: A Potential Drug Target and Biomarker

TRPC2, a member of the transient receptor potential cation channel subfamily C, is a protein that has been identified as a potential drug target and biomarker. This protein is expressed in various tissues and cells throughout the body, including the brain, heart, and pancreas, and is involved in several physiological processes, including neurotransmitter signaling, pain perception, and blood pressure regulation.

The TRPC2 gene was first identified in 2002 as a cDNA clone using the polymerase chain reaction (PCR) amplification of the genomic DNA. The gene has since been localized to the X chromosome and is predicted to encode a protein with 121 amino acid residues. The protein is a member of the TRPC family, which includes several related genes that are involved in the regulation of pain perception and neurotransmitter signaling.

TRPC2 is expressed in a variety of tissues and cells, including the brain, heart, and pancreas, and is involved in several physiological processes.

One of the key functions of TRPC2 is its role in neurotransmitter signaling. The protein is involved in the regulation of neurotransmitter release and uptake, as well as the modulation of neurotransmitter signaling by other proteins. This is important for the proper functioning of the nervous system and for the regulation of various physiological processes that rely on neurotransmitter signaling.

In addition to its role in neurotransmitter signaling, TRPC2 is also involved in pain perception. The protein is known to be involved in the regulation of pain signaling, and is thought to play a key role in the development of chronic pain. This is because TRPC2 is involved in the regulation of the release of pain-related neurotransmitters, such as serotonin and noradrenaline, which are involved in the transmission of pain signals to the brain.

Another function of TRPC2 is its role in blood pressure regulation. The protein is known to be involved in the regulation of blood pressure, and is thought to play a key role in the regulation of sodium ions in the blood. This is important for maintaining proper blood pressure and for the proper functioning of the circulatory system.

TRPC2 is also involved in the regulation of pain perception and neurotransmission.

TRPC2 has also been identified as a potential drug target. The protein is known to be involved in the regulation of pain signaling, and is thought to play a key role in the development of chronic pain. This is because TRPC2 is involved in the regulation of the release of pain-related neurotransmitters, such as serotonin and noradrenaline, which are involved in the transmission of pain signals to the brain. By targeting TRPC2, researchers may be able to develop new treatments for chronic pain.

In addition to its potential as a drug target, TRPC2 is also a potential biomarker for several diseases. The protein is expressed in a variety of tissues and cells throughout the body, including the brain, heart, and pancreas, and is involved in several physiological processes. This makes it a potential biomarker for a variety of diseases, including chronic pain, anxiety, and depression.

In conclusion, TRPC2 is a protein that has been identified as a potential drug target and biomarker. Its role in neurotransmitter signaling, pain perception, and blood pressure regulation makes it an important target for researchers to study. Further studies are needed to fully understand the functions of TRPC2 and its potential as a drug and biomarker.

Protein Name: Transient Receptor Potential Cation Channel Subfamily C Member 2 (pseudogene)

The "TRPC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRPC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets